PHARMACY

Eisai has received the FDA's approval for an expanded indication of Fycompa in pediatric patients age 4 years old and older who have seizures.

CVS Health's SilverScript Insurance is offering new Medicare Prescription Drug Plan options to help lower consumers' out-of-pocket prescription drug costs.

Teva is launching the first generic Cialis, which had a market value of about $1.93 billion for the 12 months ended July 2018, according to IQVIA data.

McKesson is celebrating its pharmacists during American Pharmacists Month with a variety of activities.

The Association for Accessible Medicines is voicing strong opposition that the proposed U.S.-Mexico-Canada trade agreement will provide a windfall for brand-name drug manufacturers and raise prescription drug prices for patients.

Perrigo confirmed that litigation has been initiated by Valeant, Dow and Kaken challenging its generic of Jublia.

Pfizer has elected Albert Bourla as CEO, succeeding Ian Read, who will serve as executive chairman of Pfizer's board of directors, effective Jan. 1, 2019.

In honor of American Pharmacists Month, which takes place each October, CVS Health is recognizing its 30,000 pharmacists.